Tactile Systems TechnologyFRA:3L3 +2.10%76 Days Payable is 31.09 as of Mar. 2026, which is 8% below its 10-year median of 33.94. GuruFocus rates FRA:3L3 with a GF Score™ of 76/100 and a GF Value™ of €16.27 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Tactile Systems Technology ranks worse than 83.27% on this metric.
The historical rank and industry rank for Tactile Systems Technology's Days Payable or its related term are showing as below:
FRA:3L3'
s Days Payable Range Over the Past 10 Years
Min: 24.41 Med: 33.94 Max: 56.58
Current: 31.8
During the past 13 years, Tactile Systems Technology's highest Days Payable was 56.58. The lowest was 24.41. And the median was 33.94.
FRA:3L3's Days Payable is ranked worse than 83.27% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:3L3: 31.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3L3 vs SSII, BVS, BBNX: Days Payable Comparison
For the Medical Devices subindustry, Tactile Systems Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's Days Payable falls into.
Tactile Systems Technology Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (FRA:3L3) has a Days Payable of 31.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tactile Systems Technology and its competitors. This is near median its historical median of 33.94. Over the past decade, Tactile Systems Technology's Days Payable has ranged from 24.41 to 56.58. According to the industry distribution chart, Tactile Systems Technology ranks #662 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 83.3%.
Is Tactile Systems Technology's Days Payable too high?
Tactile Systems Technology's current Days Payable of 31.09 is near median its 10-year median of 33.94. Over the past 10 years, this metric has ranged from a low of 24.41 to a high of 56.58. The Medical Devices & Instruments industry median Days Payable is 68.07. Tactile Systems Technology's value of 31.09 is 54.3% below this industry median. Based on the distribution chart, Tactile Systems Technology ranks #662 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tactile Systems Technology has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's Days Payable compare to SSII and BVS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #662 out of 795 companies for Days Payable. This places Tactile Systems Technology in the lower half of its industry. The industry median Days Payable is 68.07. Tactile Systems Technology's value of 31.09 is 54.3% below this benchmark. Historically, Tactile Systems Technology's own Days Payable has ranged from 24.41 to 56.58 over the past decade. While the company's 10-year median is 33.94 vs. the industry median of 68.07, Tactile Systems Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current Days Payable of 31.09 is 54.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current Days Payable is 31.09, which is near median its own 10-year median of 33.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (FRA:3L3) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.27, compared to a current price of €27.26 — trading 67.5% above its estimated fair value. The current Days Payable is 31.09, which is near median its 10-year median of 33.94 and 54.3% below the Medical Devices & Instruments industry median of 68.07. Tactile Systems Technology's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tactile Systems Technology (FRA:3L3), the current Days Payable is 31.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (FRA:3L3) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of €27.26 is trading 67.5% above its estimated GF Value™ of €16.27.
GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.
Key valuation signals for FRA:3L3:
Days Payable: 31.09 (near median its 10-year median of 33.94)
GF Value™: €16.27 vs. price of €27.26 (67.5% above fair value)
Industry Position: 54.3% below the Medical Devices & Instruments median (#662 of 795)
No single metric tells the full story. See the FRA:3L3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
76GF Score
Get the complete analysis for FRA:3L3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3L3 has been successfully added to your 
